Is Alnylam Pharmaceuticals, Inc. technically bullish or bearish?

Nov 03 2025 11:32 AM IST
share
Share Via
As of October 31, 2025, Alnylam Pharmaceuticals has a mildly bullish technical trend, supported by strong monthly indicators and a year-to-date return of 93.80%, significantly outperforming the S&P 500's 16.30%.
As of 31 October 2025, the technical trend for Alnylam Pharmaceuticals, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD, KST, and Bollinger Bands are bullish. The daily moving averages indicate a mildly bullish stance. The On-Balance Volume is bullish for both weekly and monthly periods.
In terms of performance, Alnylam has significantly outperformed the S&P 500 year-to-date with a return of 93.80% compared to the S&P 500's 16.30%, and over the past year, it has returned 71.06% versus the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, driven by strong monthly indicators and positive long-term returns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News